Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 328 entries
Sorted by: Best Match Show Resources per page
Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes.

Journal of the American College of Cardiology

Rame JE, Pagani FD, Kiernan MS, Oliveira GH, Birati EY, Atluri P, Gaffey A, Grandin EW, Myers SL, Collum C, Kormos RL, Kirklin JK, Teuteberg JJ.
PMID: 34857091
J Am Coll Cardiol. 2021 Dec 07;78(23):2294-2308. doi: 10.1016/j.jacc.2021.09.1362.

BACKGROUND: A revised definition of right heart failure (RHF) for the Society of Thoracic Surgeons Intermacs database of left ventricular assist devices (LVADs) was introduced in June 2014.OBJECTIVES: The purpose of this study was to determine the prevalence and...

Cite
Rame JE, Pagani FD, Kiernan MS, et al. Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes. J Am Coll Cardiol. 2021;78(23):2294-2308doi: 10.1016/j.jacc.2021.09.1362.
Rame, J. E., Pagani, F. D., Kiernan, M. S., Oliveira, G. H., Birati, E. Y., Atluri, P., Gaffey, A., Grandin, E. W., Myers, S. L., Collum, C., Kormos, R. L., Kirklin, J. K., & Teuteberg, J. J. (2021). Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes. Journal of the American College of Cardiology, 78(23), 2294-2308. https://doi.org/10.1016/j.jacc.2021.09.1362
Rame, J Eduardo, et al. "Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes." Journal of the American College of Cardiology vol. 78,23 (2021): 2294-2308. doi: https://doi.org/10.1016/j.jacc.2021.09.1362
Rame JE, Pagani FD, Kiernan MS, Oliveira GH, Birati EY, Atluri P, Gaffey A, Grandin EW, Myers SL, Collum C, Kormos RL, Kirklin JK, Teuteberg JJ. Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes. J Am Coll Cardiol. 2021 Dec 07;78(23):2294-2308. doi: 10.1016/j.jacc.2021.09.1362. PMID: 34857091.
Copy Download .nbib Format: NLM
Chronic aerobic exercise prevents high-fructose diet-induced impairment in blood pressure in healthy young adults: a double-blind, randomised clinical trial.

The British journal of nutrition

Vieira AF, Moritz CEJ, Ramis TR, Boeno FP, Dos Santos GC, Lisboa SC, Teodoro JL, Costa RR, Macedo RCO, Reischak-Oliveira A.
PMID: 34915947
Br J Nutr. 2021 Dec 17;1-15. doi: 10.1017/S0007114521004980. Epub 2021 Dec 17.

The purpose of the study was to verify the effect of 4 weeks of a high-fructose diet (HFD) associated with aerobic training on the risk factors for cardiometabolic diseases. Twenty-one young adults were randomised into three groups: HFD (HFD:...

Cite
Vieira AF, Moritz CEJ, Ramis TR, et al. Chronic aerobic exercise prevents high-fructose diet-induced impairment in blood pressure in healthy young adults: a double-blind, randomised clinical trial. Br J Nutr. 2021;1-15doi: 10.1017/S0007114521004980.
Vieira, A. F., Moritz, C. E. J., Ramis, T. R., Boeno, F. P., Dos Santos, G. C., Lisboa, S. C., Teodoro, J. L., Costa, R. R., Macedo, R. C. O., & Reischak-Oliveira, A. (2021). Chronic aerobic exercise prevents high-fructose diet-induced impairment in blood pressure in healthy young adults: a double-blind, randomised clinical trial. The British journal of nutrition, 1-15. https://doi.org/10.1017/S0007114521004980
Vieira, Alexandra Ferreira, et al. "Chronic aerobic exercise prevents high-fructose diet-induced impairment in blood pressure in healthy young adults: a double-blind, randomised clinical trial." The British journal of nutrition vol. (2021): 1-15. doi: https://doi.org/10.1017/S0007114521004980
Vieira AF, Moritz CEJ, Ramis TR, Boeno FP, Dos Santos GC, Lisboa SC, Teodoro JL, Costa RR, Macedo RCO, Reischak-Oliveira A. Chronic aerobic exercise prevents high-fructose diet-induced impairment in blood pressure in healthy young adults: a double-blind, randomised clinical trial. Br J Nutr. 2021 Dec 17;1-15. doi: 10.1017/S0007114521004980. Epub 2021 Dec 17. PMID: 34915947.
Copy Download .nbib Format: NLM
External quality assessment of SARS-CoV-2-sequencing: An ESGMD-SSM pilot trial across 15 European laboratories.

Journal of clinical microbiology

Wegner F, Roloff T, Huber M, Cordey S, Ramette A, Gerth Y, Bertelli C, Stange M, Seth-Smith HMB, Mari A, Leuzinger K, Cerutti L, Harshman K, Xenarios I, Le Mercier P, Bittel P, Neuenschwander S, Opota O, Fuchs J, Panning M, Michel C, Hallin M, Demuyser T, De Mendonca R, Savelkoul P, Dingemans J, van der Veer B, Boers SA, Claas ECJ, Coolen JPM, Melchers WJG, Gunell M, Kallonen T, Vuorinen T, Hakanen AJ, Bernhoff E, Hetland MAK, Berman HG, Adar S, Moran-Gilad J, Wolf DG, Leib SL, Nolte O, Kaiser L, Schmutz S, Kufner V, Zaheri M, Trkola A, Aamot HV, Hirsch HH, Greub G, Egli A.
PMID: 34757834
J Clin Microbiol. 2021 Nov 10;JCM0169821. doi: 10.1128/JCM.01698-21. Epub 2021 Nov 10.

OBJECTIVE: This first pilot on external quality assessment (EQA) of SARS-CoV-2 whole genome sequencing, initiated by the ESCMID Study Group for Genomic and Molecular Diagnostics (ESGMD) and Swiss Society for Microbiology (SSM), aims to build a framework between laboratories...

Cite
Wegner F, Roloff T, Huber M, et al. External quality assessment of SARS-CoV-2-sequencing: An ESGMD-SSM pilot trial across 15 European laboratories. J Clin Microbiol. 2021;JCM0169821doi: 10.1128/JCM.01698-21.
Wegner, F., Roloff, T., Huber, M., Cordey, S., Ramette, A., Gerth, Y., Bertelli, C., Stange, M., Seth-Smith, H. M. B., Mari, A., Leuzinger, K., Cerutti, L., Harshman, K., Xenarios, I., Le Mercier, P., Bittel, P., Neuenschwander, S., Opota, O., Fuchs, J., Panning, M., Michel, C., Hallin, M., Demuyser, T., De Mendonca, R., Savelkoul, P., Dingemans, J., van der Veer, B., Boers, S. A., Claas, E. C. J., Coolen, J. P. M., Melchers, W. J. G., Gunell, M., Kallonen, T., Vuorinen, T., Hakanen, A. J., Bernhoff, E., Hetland, M. A. K., Berman, H. G., Adar, S., Moran-Gilad, J., Wolf, D. G., Leib, S. L., Nolte, O., Kaiser, L., Schmutz, S., Kufner, V., Zaheri, M., Trkola, A., Aamot, H. V., Hirsch, H. H., Greub, G., & Egli, A. (2021). External quality assessment of SARS-CoV-2-sequencing: An ESGMD-SSM pilot trial across 15 European laboratories. Journal of clinical microbiology, JCM0169821. https://doi.org/10.1128/JCM.01698-21
Wegner, Fanny, et al. "External quality assessment of SARS-CoV-2-sequencing: An ESGMD-SSM pilot trial across 15 European laboratories." Journal of clinical microbiology vol. (2021): JCM0169821. doi: https://doi.org/10.1128/JCM.01698-21
Wegner F, Roloff T, Huber M, Cordey S, Ramette A, Gerth Y, Bertelli C, Stange M, Seth-Smith HMB, Mari A, Leuzinger K, Cerutti L, Harshman K, Xenarios I, Le Mercier P, Bittel P, Neuenschwander S, Opota O, Fuchs J, Panning M, Michel C, Hallin M, Demuyser T, De Mendonca R, Savelkoul P, Dingemans J, van der Veer B, Boers SA, Claas ECJ, Coolen JPM, Melchers WJG, Gunell M, Kallonen T, Vuorinen T, Hakanen AJ, Bernhoff E, Hetland MAK, Berman HG, Adar S, Moran-Gilad J, Wolf DG, Leib SL, Nolte O, Kaiser L, Schmutz S, Kufner V, Zaheri M, Trkola A, Aamot HV, Hirsch HH, Greub G, Egli A. External quality assessment of SARS-CoV-2-sequencing: An ESGMD-SSM pilot trial across 15 European laboratories. J Clin Microbiol. 2021 Nov 10;JCM0169821. doi: 10.1128/JCM.01698-21. Epub 2021 Nov 10. PMID: 34757834.
Copy Download .nbib Format: NLM
Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization.

The American journal of cardiology

Lyu B, Grams ME, Chang A, Inker LA, Coresh J, Shin JI.
PMID: 34937658
Am J Cardiol. 2022 Feb 15;165:124-130. doi: 10.1016/j.amjcard.2021.11.013. Epub 2021 Dec 20.

Clinical trials have demonstrated cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA). However, their impact on all-cause and cause-specific hospitalization in real-world practice remains unclear. We identified patients with diabetes who initiated SGLT2i...

Cite
Lyu B, Grams ME, Chang A, et al. Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization. Am J Cardiol. 2021;165:124-130doi: 10.1016/j.amjcard.2021.11.013.
Lyu, B., Grams, M. E., Chang, A., Inker, L. A., Coresh, J., & Shin, J. I. (2022). Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization. The American journal of cardiology, 165124-130. https://doi.org/10.1016/j.amjcard.2021.11.013
Lyu, Beini, et al. "Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization." The American journal of cardiology vol. 165 (2022): 124-130. doi: https://doi.org/10.1016/j.amjcard.2021.11.013
Lyu B, Grams ME, Chang A, Inker LA, Coresh J, Shin JI. Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Dipeptidyl Peptidase-4 Inhibitors, and Risk of Hospitalization. Am J Cardiol. 2022 Feb 15;165:124-130. doi: 10.1016/j.amjcard.2021.11.013. Epub 2021 Dec 20. PMID: 34937658.
Copy Download .nbib Format: NLM
3 Cases of Superior Vena Cava Syndrome Following Percutaneous Right Ventricular Assist Device Placement.

JACC. Case reports

Vaile JR, Rame JE, Alvarez RJ, Massey HT, Tchantchaleishvili V, Vishnevsky A, Rajapreyar IN, Brailovsky Y, Shah MK.
PMID: 34766020
JACC Case Rep. 2021 Nov 03;3(15):1690-1693. doi: 10.1016/j.jaccas.2021.09.005. eCollection 2021 Nov 03.

We present 3 cases of superior vena cava (SVC) syndrome following percutaneous right ventricular assist device (RVAD) placement. Each case underscores the importance of early recognition of SVC syndrome in patients with percutaneous RVAD insertion via the internal jugular...

Cite
Vaile JR, Rame JE, Alvarez RJ, et al. 3 Cases of Superior Vena Cava Syndrome Following Percutaneous Right Ventricular Assist Device Placement. JACC Case Rep. 2021;3(15):1690-1693doi: 10.1016/j.jaccas.2021.09.005.
Vaile, J. R., Rame, J. E., Alvarez, R. J., Massey, H. T., Tchantchaleishvili, V., Vishnevsky, A., Rajapreyar, I. N., Brailovsky, Y., & Shah, M. K. (2021). 3 Cases of Superior Vena Cava Syndrome Following Percutaneous Right Ventricular Assist Device Placement. JACC. Case reports, 3(15), 1690-1693. https://doi.org/10.1016/j.jaccas.2021.09.005
Vaile, John R, et al. "3 Cases of Superior Vena Cava Syndrome Following Percutaneous Right Ventricular Assist Device Placement." JACC. Case reports vol. 3,15 (2021): 1690-1693. doi: https://doi.org/10.1016/j.jaccas.2021.09.005
Vaile JR, Rame JE, Alvarez RJ, Massey HT, Tchantchaleishvili V, Vishnevsky A, Rajapreyar IN, Brailovsky Y, Shah MK. 3 Cases of Superior Vena Cava Syndrome Following Percutaneous Right Ventricular Assist Device Placement. JACC Case Rep. 2021 Nov 03;3(15):1690-1693. doi: 10.1016/j.jaccas.2021.09.005. eCollection 2021 Nov 03. PMID: 34766020; PMCID: PMC8571785.
Copy Download .nbib Format: NLM
Evaluation of whole-genome sequence data analysis approaches for short- and long-read sequencing of .

Microbial genomics

Peker N, Schuele L, Kok N, Terrazos M, Neuenschwander SM, de Beer J, Akkerman O, Peter S, Ramette A, Merker M, Niemann S, Couto N, Sinha B, Rossen JW.
PMID: 34825880
Microb Genom. 2021 Nov;7(11). doi: 10.1099/mgen.0.000695.

No abstract available.

Cite
Peker N, Schuele L, Kok N, et al. Evaluation of whole-genome sequence data analysis approaches for short- and long-read sequencing of . Microb Genom. 2021;7(11)doi: 10.1099/mgen.0.000695.
Peker, N., Schuele, L., Kok, N., Terrazos, M., Neuenschwander, S. M., de Beer, J., Akkerman, O., Peter, S., Ramette, A., Merker, M., Niemann, S., Couto, N., Sinha, B., & Rossen, J. W. (2021). Evaluation of whole-genome sequence data analysis approaches for short- and long-read sequencing of . Microbial genomics, 7(11), . https://doi.org/10.1099/mgen.0.000695
Peker, Nilay, et al. "Evaluation of whole-genome sequence data analysis approaches for short- and long-read sequencing of ." Microbial genomics vol. 7,11 (2021). doi: https://doi.org/10.1099/mgen.0.000695
Peker N, Schuele L, Kok N, Terrazos M, Neuenschwander SM, de Beer J, Akkerman O, Peter S, Ramette A, Merker M, Niemann S, Couto N, Sinha B, Rossen JW. Evaluation of whole-genome sequence data analysis approaches for short- and long-read sequencing of . Microb Genom. 2021 Nov;7(11). doi: 10.1099/mgen.0.000695. PMID: 34825880.
Copy Download .nbib Format: NLM
Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry.

Journal of neurology

Tütüncü S, Olma M, Kunze C, Dietzel J, Schurig J, Fiessler C, Malsch C, Haas TE, Dimitrijeski B, Doehner W, Hagemann G, Hamilton F, Honermann M, Jungehulsing GJ, Kauert A, Koennecke HC, Mackert BM, Nabavi D, Nolte CH, Reis JM, Schmehl I, Sparenberg P, Stingele R, Völzke E, Waldschmidt C, Zeise-Wehry D, Heuschmann PU, Endres M, Haeusler KG.
PMID: 34837502
J Neurol. 2022 Jan;269(1):481-482. doi: 10.1007/s00415-021-10907-w.

No abstract available.

Cite
Tütüncü S, Olma M, Kunze C, et al. Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry. J Neurol. 2022;269(1):481-482doi: 10.1007/s00415-021-10907-w.
Tütüncü, S., Olma, M., Kunze, C., Dietzel, J., Schurig, J., Fiessler, C., Malsch, C., Haas, T. E., Dimitrijeski, B., Doehner, W., Hagemann, G., Hamilton, F., Honermann, M., Jungehulsing, G. J., Kauert, A., Koennecke, H. C., Mackert, B. M., Nabavi, D., Nolte, C. H., Reis, J. M., Schmehl, I., Sparenberg, P., Stingele, R., Völzke, E., Waldschmidt, C., Zeise-Wehry, D., Heuschmann, P. U., Endres, M., & Haeusler, K. G. (2022). Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry. Journal of neurology, 269(1), 481-482. https://doi.org/10.1007/s00415-021-10907-w
Tütüncü, Serdar, et al. "Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry." Journal of neurology vol. 269,1 (2022): 481-482. doi: https://doi.org/10.1007/s00415-021-10907-w
Tütüncü S, Olma M, Kunze C, Dietzel J, Schurig J, Fiessler C, Malsch C, Haas TE, Dimitrijeski B, Doehner W, Hagemann G, Hamilton F, Honermann M, Jungehulsing GJ, Kauert A, Koennecke HC, Mackert BM, Nabavi D, Nolte CH, Reis JM, Schmehl I, Sparenberg P, Stingele R, Völzke E, Waldschmidt C, Zeise-Wehry D, Heuschmann PU, Endres M, Haeusler KG. Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry. J Neurol. 2022 Jan;269(1):481-482. doi: 10.1007/s00415-021-10907-w. PMID: 34837502.
Copy Download .nbib Format: NLM
A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease.

Kidney international

Hu JR, Myint L, Levey AS, Coresh J, Inker LA, Grams ME, Guallar E, Hansen KD, Rhee EP, Shafi T.
PMID: 34843755
Kidney Int. 2021 Nov 26; doi: 10.1016/j.kint.2021.10.035. Epub 2021 Nov 26.

Uremic symptoms are common in patients with advanced chronic kidney disease, but the toxins that cause these symptoms are unknown. To evaluate this, we performed a cross-sectional study of the 12 month post-randomization follow-up visit of Modification of Diet...

Cite
Hu JR, Myint L, Levey AS, et al. A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease. Kidney Int. 2021;doi: 10.1016/j.kint.2021.10.035.
Hu, J. R., Myint, L., Levey, A. S., Coresh, J., Inker, L. A., Grams, M. E., Guallar, E., Hansen, K. D., Rhee, E. P., & Shafi, T. (2021). A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease. Kidney international, . https://doi.org/10.1016/j.kint.2021.10.035
Hu, Jiun-Ruey, et al. "A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease." Kidney international vol. (2021). doi: https://doi.org/10.1016/j.kint.2021.10.035
Hu JR, Myint L, Levey AS, Coresh J, Inker LA, Grams ME, Guallar E, Hansen KD, Rhee EP, Shafi T. A metabolomics approach identified toxins associated with uremic symptoms in advanced chronic kidney disease. Kidney Int. 2021 Nov 26; doi: 10.1016/j.kint.2021.10.035. Epub 2021 Nov 26. PMID: 34843755.
Copy Download .nbib Format: NLM
Infective endocarditis following heart transplantation: A systematic review.

Transplantation reviews (Orlando, Fla.)

Jordan AM, Tatum R, Ahmad D, Patel SV, Maynes EJ, Weber MP, Moss S, Royer TL, Tchantchaleishvili V, Massey HT, Rame JE, Zurlo JJ, Aburjania N.
PMID: 34826752
Transplant Rev (Orlando). 2021 Nov 06;36(1):100672. doi: 10.1016/j.trre.2021.100672. Epub 2021 Nov 06.

PURPOSE: Infective endocarditis (IE) is a rare but potentially fatal complication following heart transplantation (HTx). There is a lack of literature regarding the patterns and clinical course of IE development following HTx. We sought to pool the existing data...

Cite
Jordan AM, Tatum R, Ahmad D, et al. Infective endocarditis following heart transplantation: A systematic review. Transplant Rev (Orlando). 2021;36(1):100672doi: 10.1016/j.trre.2021.100672.
Jordan, A. M., Tatum, R., Ahmad, D., Patel, S. V., Maynes, E. J., Weber, M. P., Moss, S., Royer, T. L., Tchantchaleishvili, V., Massey, H. T., Rame, J. E., Zurlo, J. J., & Aburjania, N. (2021). Infective endocarditis following heart transplantation: A systematic review. Transplantation reviews (Orlando, Fla.), 36(1), 100672. https://doi.org/10.1016/j.trre.2021.100672
Jordan, Andrew M, et al. "Infective endocarditis following heart transplantation: A systematic review." Transplantation reviews (Orlando, Fla.) vol. 36,1 (2021): 100672. doi: https://doi.org/10.1016/j.trre.2021.100672
Jordan AM, Tatum R, Ahmad D, Patel SV, Maynes EJ, Weber MP, Moss S, Royer TL, Tchantchaleishvili V, Massey HT, Rame JE, Zurlo JJ, Aburjania N. Infective endocarditis following heart transplantation: A systematic review. Transplant Rev (Orlando). 2021 Nov 06;36(1):100672. doi: 10.1016/j.trre.2021.100672. Epub 2021 Nov 06. PMID: 34826752.
Copy Download .nbib Format: NLM
Energy metabolism measured by 31P magnetic resonance spectroscopy in the healthy human brain.

Journal of neuroradiology = Journal de neuroradiologie

Rietzler A, Steiger R, Mangesius S, Walchhofer LM, Gothe RM, Schocke M, Gizewski ER, Grams AE.
PMID: 34871672
J Neuroradiol. 2021 Dec 04; doi: 10.1016/j.neurad.2021.11.006. Epub 2021 Dec 04.

BACKGROUND AND PURPOSE: Phosphorous magnetic resonance spectroscopy (31P-MRS) allows a non-invasive analysis of phosphorus-containing compounds in vivo. The present study investigated the influence of brain region, hemisphere, age, sex and brain volume on 31P-MRS metabolites in healthy adults.MATERIALS AND...

Cite
Rietzler A, Steiger R, Mangesius S, et al. Energy metabolism measured by 31P magnetic resonance spectroscopy in the healthy human brain. J Neuroradiol. 2021;doi: 10.1016/j.neurad.2021.11.006.
Rietzler, A., Steiger, R., Mangesius, S., Walchhofer, L. M., Gothe, R. M., Schocke, M., Gizewski, E. R., & Grams, A. E. (2021). Energy metabolism measured by 31P magnetic resonance spectroscopy in the healthy human brain. Journal of neuroradiology = Journal de neuroradiologie, . https://doi.org/10.1016/j.neurad.2021.11.006
Rietzler, Andreas, et al. "Energy metabolism measured by 31P magnetic resonance spectroscopy in the healthy human brain." Journal of neuroradiology = Journal de neuroradiologie vol. (2021). doi: https://doi.org/10.1016/j.neurad.2021.11.006
Rietzler A, Steiger R, Mangesius S, Walchhofer LM, Gothe RM, Schocke M, Gizewski ER, Grams AE. Energy metabolism measured by 31P magnetic resonance spectroscopy in the healthy human brain. J Neuroradiol. 2021 Dec 04; doi: 10.1016/j.neurad.2021.11.006. Epub 2021 Dec 04. PMID: 34871672.
Copy Download .nbib Format: NLM
Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producer.

Journal of global antimicrobial resistance

Moser AI, Campos-Madueno EI, Sendi P, Perreten V, Keller PM, Ramette A, Endimiani A.
PMID: 34718203
J Glob Antimicrob Resist. 2021 Oct 28;27:267-272. doi: 10.1016/j.jgar.2021.10.012. Epub 2021 Oct 28.

OBJECTIVES: Patients hospitalised abroad can become colonised with multidrug-resistant bacteria and import them to their home countries. In this study, we characterised an OXA-484 carbapenemase-producing Escherichia coli strain from a Swiss patient infected by SARS-CoV-2 and repatriated from India.METHODS:...

Cite
Moser AI, Campos-Madueno EI, Sendi P, et al. Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producer. J Glob Antimicrob Resist. 2021;27:267-272doi: 10.1016/j.jgar.2021.10.012.
Moser, A. I., Campos-Madueno, E. I., Sendi, P., Perreten, V., Keller, P. M., Ramette, A., & Endimiani, A. (2021). Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producer. Journal of global antimicrobial resistance, 27267-272. https://doi.org/10.1016/j.jgar.2021.10.012
Moser, Aline I, et al. "Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producer." Journal of global antimicrobial resistance vol. 27 (2021): 267-272. doi: https://doi.org/10.1016/j.jgar.2021.10.012
Moser AI, Campos-Madueno EI, Sendi P, Perreten V, Keller PM, Ramette A, Endimiani A. Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producer. J Glob Antimicrob Resist. 2021 Oct 28;27:267-272. doi: 10.1016/j.jgar.2021.10.012. Epub 2021 Oct 28. PMID: 34718203; PMCID: PMC8552635.
Copy Download .nbib Format: NLM
[No title available]

Clinical journal of the American Society of Nephrology : CJASN

Luo S, Surapaneni A, Zheng Z, Rhee EP, Coresh J, Hung AM, Nadkarni GN, Yu B, Boerwinkle E, Tin A, Arking DE, Steinbrenner I, Schlosser P, Köttgen A, Grams ME.
PMID: 33380473
Clin J Am Soc Nephrol. 2020 Dec 31;16(1):37-47. doi: 10.2215/CJN.08600520.

BACKGROUND AND OBJECTIVES: Genetic variants in DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We conducted analyses among participants with genetic and/or serum metabolomic data in the African American Study of Kidney Disease and Hypertension (AASK; RESULTS: Of 31 N-acetylated amino acids...

Cite
Luo S, Surapaneni A, Zheng Z, et al. . Clin J Am Soc Nephrol. 2020;16(1):37-47doi: 10.2215/CJN.08600520.
Luo, S., Surapaneni, A., Zheng, Z., Rhee, E. P., Coresh, J., Hung, A. M., Nadkarni, G. N., Yu, B., Boerwinkle, E., Tin, A., Arking, D. E., Steinbrenner, I., Schlosser, P., Köttgen, A., & Grams, M. E. (2020). . Clinical journal of the American Society of Nephrology : CJASN, 16(1), 37-47. https://doi.org/10.2215/CJN.08600520
Luo, Shengyuan, et al. "." Clinical journal of the American Society of Nephrology : CJASN vol. 16,1 (2020): 37-47. doi: https://doi.org/10.2215/CJN.08600520
Luo S, Surapaneni A, Zheng Z, Rhee EP, Coresh J, Hung AM, Nadkarni GN, Yu B, Boerwinkle E, Tin A, Arking DE, Steinbrenner I, Schlosser P, Köttgen A, Grams ME. . Clin J Am Soc Nephrol. 2020 Dec 31;16(1):37-47. doi: 10.2215/CJN.08600520. PMID: 33380473; PMCID: PMC7792648.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 328 entries